Advanced search
Publication Cover
Acta Oncologica Volume 35, 1996 - Issue sup8
Journal homepage
243
Views
19
CrossRef citations to date
0
Altmetric
Original Article

Survival After Curative Treatment of Muscle-Invasive Bladder Cancer

Sophie D. Fosså Department of Medical Oncology and Radiotherapy
,
Nina Aass Department of Medical Oncology and Radiotherapy
,
Sigurd Ous Department of Surgical Oncology
,
Hakon Wéhre Department of Surgical Oncology
,
Kari Ilner Department of Medical Oncology and Radiotherapy
&
Einar Hannisdal Clinical Research Office
Pages 59-65 | Published online: 08 Jul 2009

Citations (19)

Keep up to date with the latest research on this topic with citation updates for this article.

Subscribe to citation updates

Read on this site (1)

Hans Hedelin, Sten Holmäng & Lena Wiman. (2002) The Cost of Bladder Tumour Treatment and Follow-up. Scandinavian Journal of Urology and Nephrology 36:5, pages 344-347.
Read now

Articles from other publishers (18)

Judy Hamad, Hannah McCloskey, Matthew I. Milowsky, Trevor Royce & Angela Smith. (2020) Bladder preservation in muscle-invasive bladder cancer: a comprehensive review. International braz j urol 46:2, pages 169-184.
Crossref
Jian Cao, Xiaokun Zhao, Zhaohui Zhong, Lei Zhang, Xuan Zhu & Ran Xu. (2016) Prognostic Value of Pre-operative Renal Insufficiency in Urothelial Carcinoma: A Systematic Review and Meta-Analysis. Scientific Reports 6:1.
Crossref
Soojong Park, Ahmad Fudhaili, Sang-Seok Oh, Ki Won Lee, Hamadi Madhi, Dong-Hee Kim, Jiyun Yoo, Hyung Won Ryu, Ki-Hun Park & Kwang Dong Kim. (2016) Cytotoxic effects of kazinol A derived from Broussonetia papyrifera on human bladder cancer cells, T24 and T24R2. Phytomedicine 23:12, pages 1462-1468.
Crossref
Omar M. S. El-Taji, Sameer Alam & Syed A. Hussain. (2016) Bladder Sparing Approaches for Muscle-Invasive Bladder Cancers. Current Treatment Options in Oncology 17:3.
Crossref
Shahrokh F Shariat & Evanguelos XylinasAnanya Choudhury, Robert A Huddart & Anne E Kiltie. 2015. Advances in Bladder Cancer Management. Advances in Bladder Cancer Management 158 173 .
DU G. MOON, SANG E. LEE, MI M. OH, SANG C. LEE, SEONG J. JEONG, SUNG K. HONG, CHEOL Y. YOON, SEOK S. BYUN, HONG S. PARK & JUN CHEON. (2014) NVP-BEZ235, a dual PI3K/mTOR inhibitor synergistically potentiates the antitumor effects of cisplatin in bladder cancer cells. International Journal of Oncology 45:3, pages 1027-1035.
Crossref
Paola Pinnarò, Carolina Giordano, Giuseppe Giovinazzo & Biancamaria Saracino. (2013) The Role of Radiotherapy in Bladder Cancer. Urologia Journal 80:3, pages 202-206.
Crossref
Zachary L. Smith, John P. Christodouleas, Stephen M. Keefe, S. Bruce Malkowicz & Thomas J. Guzzo. (2013) Bladder preservation in the treatment of muscle‐invasive bladder cancer ( MIBC ): a review of the literature and a practical approach to therapy . BJU International 112:1, pages 13-25.
Crossref
Ping Jiang & Juergen Dunst. 2014. Decision Tools for Radiation Oncology. Decision Tools for Radiation Oncology 221 229 .
Gustavo Nader Marta, Samir Abdallah Hanna, Rafael Gadia, Sebastião Francisco Miranda Correa, Joao Luis Fernandes da Silva & Heloisa de Andrade Carvalho. (2012) The role of radiotherapy in urinary bladder cancer: current status. International braz j urol 38:2, pages 144-156.
Crossref
Cheol Yong Yoon, Mi Jung Park, Jung Sun Lee, Sang Chul Lee, Jong Jin Oh, Hongzoo Park, Chang Wook Chung, Murod M. Abdullajanov, Seong Jin Jeong, Sung Kyu Hong, Seok Soo Byun, Eun Sik Lee & Sang Eun Lee. (2011) The Histone Deacetylase Inhibitor Trichostatin A Synergistically Resensitizes a Cisplatin Resistant Human Bladder Cancer Cell Line. Journal of Urology 185:3, pages 1102-1111.
Crossref
Se Jun ParkTae Jin LeeIn Ho Chang. (2011) Role of the mTOR Pathway in the Progression and Recurrence of Bladder Cancer: An Immunohistochemical Tissue Microarray Study. Korean Journal of Urology 52:7, pages 466.
Crossref
Cheol Yong YoonJung Sun LeeBo Sun KimSeong Jin JeongSung Kyu Hong, Seok Soo ByunSang Eun Lee. (2011) Sunitinib Malate Synergistically Potentiates Anti-Tumor Effect of Gemcitabine in Human Bladder Cancer Cells. Korean Journal of Urology 52:1, pages 55.
Crossref
James S. Butler. 2008. Radiation Oncology. Radiation Oncology 283 298 .
H.G. van der Poel, N. Antonini, H. van Tinteren & S. Horenblas. (2005) Upper Urinary Tract Cancer: Location is Correlated with Prognosis. European Urology 48:3, pages 438-444.
Crossref
M.M Knap, F Lundbeck & J Overgaard. (2003) The role of pelvic lymph node dissection as a predictive and prognostic factor in bladder cancer. European Journal of Cancer 39:5, pages 604-613.
Crossref
Mark R Feneley & Mark Schoenberg. (2000) Bladder-sparing strategies for transitional cell carcinoma. Urology 56:4, pages 549-560.
Crossref
L. Dæhlin, S. Haukaas, H. Maartmann-Moe & P.C. Medby. (1999) Survival after radical treatment for transitional cell carcinoma of the bladder. European Journal of Surgical Oncology (EJSO) 25:1, pages 66-70.
Crossref

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Order Reprints Request Corporate Permissions

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

Request Academic Permissions

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.

Related research

People also read lists articles that other readers of this article have read.

Recommended articles lists articles that we recommend and is powered by our AI driven recommendation engine.

Cited by lists all citing articles based on Crossref citations.
Articles with the Crossref icon will open in a new tab.